Clinical trial
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term…
NCT00058188 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00058188 |
|---|---|
| Title | Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation |
| Official title | A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation |
| Lead sponsor | Northwestern University, Other |
| Collaborators | Novartis Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Prostate Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | cholecalciferol, calcium gluconate, zoledronic acid |
| Enrollment | 53 |
| Start date | Mar 1, 2003 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Apr 9, 2003 |
| Last update posted | Dec 8, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: